Ruediger Weseloh

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Ruediger Weseloh
Non-Executive Director / Nyrada Inc

Mr Weseloh is a Director of Business Development at Merck KgaA, Darmstadt, Germany, where, in 14 years of doing BD, he has led it's transactions for the pharmaceutical division, doing deals across the drug development value chain in the fields of Oncology, Rheumatology, Neurodegenerative diseases, and Fertility. Before Merck KgaA, he spent 5 years as a Biotech/Pharma Equity Analyst, at Gontard & Metallbank, Frankfurt, and Sal. Oppenheim, Cologne/Frankfurt, as well as 3 years as a Postdoc at the Max-Planck-Institute for Medicine in Goettingen. He also serves on the Supervisory Board of Cytotools AG, Freiburg, Germany.

Lists and Charts

Total Shareholder Return as at 05/02/26

Rank Company 1 Yr 5 Yr
16th African Gold 1201.67% 40.16%
17th ASF Group 1151.28% 0.93%
18th Nyrada Inc 1035.08% 16.6%
19th Finder Energy 1011.22% 0%
20th Oakajee Corporation 938.74% 9.39%
View Full List
1663 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

05/12/25
$30.00k Issued
Nyrada Inc
12/06/24
$20.00k Issued
Nyrada Inc
14/03/24
Other
Nyrada Inc
Total value as at the date of the transaction
Powered by Morningstar ®

      Person Activity

      		 NEW ROLE: Non-Executive Director, Nyrada Inc 03 Nov 2020

    Related Information

    Access to our data for Ruediger Weseloh is only available to paid subscribers with Data & Insights access.

    Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

    Ruediger Weseloh is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

    To see the data you will need to Subscribe.

    X